News | November 06, 2025
Ginkgo Bioworks and Bayer renew partnership to power the next wave of Ag Biologicals
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Findings likely to generate hypotheses about potential new uses of drugs
Groundbreaking collaboration harnesses AI-driven insights and advanced manufacturing to create next-generation adjuvants for emerging biological threats
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Dr. Mahdavi will lead Ginkgo's commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities.
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
Subscribe To Our Newsletter & Stay Updated
